bluebird bio Inc at Jefferies Cell Therapy Summit Transcript
Welcome, everyone. Day 2 of Jeffrey Cell Therapy Summit. We've got bluebird bio. But before I introduce them, I've got my colleague, Kelly Shi, who's on my team, who is going to help moderate this fireside chat.
So I'd like to introduce Philip Gregory, bluebird's Chief Scientific Officer; and Chip Baird, their Chief Financial Officer.
Questions & Answers
So maybe, I guess, let's just start off with overview. What can we expect in terms of data at ASH? Can you just talk about maybe things that we should expect over the next few months from the pipeline?
Yes, sure. Thanks, Biren, and thanks for inviting us to be a part of the conference day. It's great to be here in a virtual setting. So yes, I think it's going to be an eventful fourth quarter for us, it's been an eventful year so
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |